CoChat

CD38 in Neurodegeneration and Neuroinflammation

Open access
Guerreiro, Serge, Privat, Anne-Laure, Bressac, Laurence, Toulorge, Damien · 2020 · Cells
Cited by 141

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Abstract

Neurodegenerative diseases are characterized by neuronal degeneration as well as neuroinflammation. While CD38 is strongly expressed in brain cells including neurons, astrocytes as well as microglial cells, the role played by CD38 in neurodegeneration and neuroinflammation remains elusive. Yet, CD38 expression increases as a consequence of aging which is otherwise the primary risk associated with neurodegenerative diseases, and several experimental data demonstrated that CD38 knockout mice are protected from neurodegenerative and neuroinflammatory insults. Moreover, nicotinamide adenine dinucleotide, whose levels are tightly controlled by CD38, is a recognized and potent neuroprotective agent, and NAD supplementation was found to be beneficial against neurodegenerative diseases. The aims of this review are to summarize the physiological role played by CD38 in the brain, present the arguments indicating the involvement of CD38 in neurodegeneration and neuroinflammation, and to discuss these observations in light of CD38 complex biology.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cells9020471

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Research works printed but not linked: 57

  1. Gan, 2018, Converging pathways in neurodegeneration, from genetics to mechanisms, Nat. Neurosci., 21, 1300, 10.1038/s41593-018-0237-7 · DOI · Paper page
  2. Mehta, 2017, Why do trials for Alzheimer’s disease drugs keep failing? A discontinued drug perspective for 2010-2015, Expert Opin. Investig. Drugs, 26, 735, 10.1080/13543784.2017.1323868 · DOI · Paper page
  3. Clement, 2018, The Plasma NAD + Metabolome Is Dysregulated in “Normal” Aging, Rejuvenation Res., 22, 121, 10.1089/rej.2018.2077 · DOI · Paper page
  4. Zhu, 2015, In vivo NAD assay reveals the intracellular NAD contents and redox state in healthy human brain and their age dependences, Proc. Natl. Acad. Sci. USA, 112, 2876, 10.1073/pnas.1417921112 · DOI · Paper page
  5. Chini, 2009, CD38 as a regulator of cellular NAD: a novel potential pharmacological target for metabolic conditions, Curr. Pharm. Des., 15, 57, 10.2174/138161209787185788 · DOI · Paper page
  6. Chini, 2016, CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism, Cell Metab., 23, 1127, 10.1016/j.cmet.2016.05.006 · DOI · Paper page
  7. Aarhus, 1995, ADP-ribosyl cyclase and CD38 catalyze the synthesis of a calcium-mobilizing metabolite from NADP, J. Biol. Chem., 270, 30327, 10.1074/jbc.270.51.30327 · DOI · Paper page
  8. Deaglio, 1998, Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member, J. Immunol., 160, 395, 10.4049/jimmunol.160.1.395 · DOI · Paper page
  9. Horenstein, 1998, CD38 binding to human myeloid cells is mediated by mouse and human CD31, Biochem. J., 330, 1129, 10.1042/bj3301129 · DOI
  10. Newman, 2003, Signal Transduction Pathways Mediated by PECAM-1, Arterioscler. Thromb. Vasc. Biol., 23, 953, 10.1161/01.ATV.0000071347.69358.D9 · DOI · Paper page
  11. Kalinowska, 2006, PECAM-1, a key player in neuroinflammation, Eur. J. Neurol., 13, 1284, 10.1111/j.1468-1331.2006.01640.x · DOI · Paper page
  12. Fang, 2018, CD38 produces nicotinic acid adenosine dinucleotide phosphate in the lysosome, J. Biol. Chem., 293, 8151, 10.1074/jbc.RA118.002113 · DOI
  13. Zubiaur, 2002, CD38 Is Associated with Lipid Rafts and upon Receptor Stimulation Leads to Akt/Protein Kinase B and Erk Activation in the Absence of the CD3-ζ Immune Receptor Tyrosine-based Activation Motifs, J. Biol. Chem., 277, 13, 10.1074/jbc.M107474200 · DOI
  14. Ceni, 2003, CD38-dependent ADP-ribosyl cyclase activity in developing and adult mouse brain, Biochem. J., 370, 175, 10.1042/bj20020604 · DOI · Paper page
  15. Yamada, 1997, Ultrastructural localization of CD38 immunoreactivity in rat brain, Brain Res., 756, 52, 10.1016/S0006-8993(97)00117-0 · DOI
  16. Braidy, 2014, Mapping NAD+ metabolism in the brain of ageing Wistar rats: potential targets for influencing brain senescence, Biogerontology, 15, 177, 10.1007/s10522-013-9489-5 · DOI · Paper page
  17. Ma, 2014, CD38 plays key roles in both antioxidation and cell survival of H2O2-treated primary rodent astrocytes, Int. J. Physiol. Pathophysiol. Pharmacol., 6, 102
  18. Mamik, 2011, HIV-1 and IL-1β regulate astrocytic CD38 through mitogen-activated protein kinases and nuclear factor-κB signaling mechanisms, J. Neuroinflamm., 8, 145, 10.1186/1742-2094-8-145 · DOI
  19. Kou, 2009, CD38 regulation in activated astrocytes: Implications for neuroinflammation and HIV-1 brain infection, J. Neurosci. Res., 87, 2326, 10.1002/jnr.22060 · DOI · Paper page
  20. Verderio, 2001, Evidence of a role for cyclic ADP-ribose in calcium signalling and neurotransmitter release in cultured astrocytes, J. Neurochem., 78, 646, 10.1046/j.1471-4159.2001.00455.x · DOI · Paper page
  21. Ma, 2012, CD38 is a key enzyme for the survival of mouse microglial BV2 cells, Biochem. Biophys. Res. Commun., 418, 714, 10.1016/j.bbrc.2012.01.084 · DOI
  22. Ma, 2014, Basal CD38/cyclic ADP-ribose-dependent signaling mediates ATP release and survival of microglia by modulating connexin 43 hemichannels, Glia, 62, 943, 10.1002/glia.22651 · DOI · Paper page
  23. Mayo, 2008, Dual Role of CD38 in Microglial Activation and Activation-Induced Cell Death, J. Immunol., 181, 92, 10.4049/jimmunol.181.1.92 · DOI · Paper page
  24. Aksoy, 2006, Regulation of intracellular levels of NAD: A novel role for CD38, Biochem. Biophys. Res. Commun., 345, 1386, 10.1016/j.bbrc.2006.05.042 · DOI · Paper page
  25. Nelissen, 2018, CD38 is Required for Dendritic Organization in Visual Cortex and Hippocampus, Neuroscience, 372, 114, 10.1016/j.neuroscience.2017.12.050 · DOI
  26. Higashida, 2007, Cyclic ADP-ribose as a universal calcium signal molecule in the nervous system, Neurochem. Int., 51, 192, 10.1016/j.neuint.2007.06.023 · DOI
  27. Ceni, 2003, Evidence for an Intracellular ADP-ribosyl Cyclase/NAD+-glycohydrolase in Brain from CD38-deficient Mice, J. Biol. Chem., 278, 40670, 10.1074/jbc.M301196200 · DOI · Paper page
  28. Soares, 2006, NAADP as a second messenger: neither CD38 nor base-exchange reaction are necessary for in vivo generation of NAADP in myometrial cells, AJP Cell Physiol., 292, C227, 10.1152/ajpcell.00638.2005 · DOI · Paper page
  29. Martucci, 2019, A multiscale analysis in CD38 −/− mice unveils major prefrontal cortex dysfunctions, FASEB J., 33, 5823, 10.1096/fj.201800489R · DOI
  30. Lee, M.R., Shin, J.H., Deschaine, S., Daurio, A.M., Stangl, B.L., Yan, J., Ramchandani, V.A., Schwandt, M.L., Grodin, E.N., and Momenan, R. (2019). A role for the CD38 rs3796863 polymorphism in alcohol and monetary reward: evidence from CD38 knockout mice and alcohol self-administration, [11C]-raclopride binding, and functional MRI in humans. Am. J. Drug Alcohol Abuse, 1–13. · DOI
  31. Demeule, 2001, Isolation of endothelial cells from brain, lung, and kidney: Expression of the multidrug resistance p-glycoprotein isoforms, Biochem. Biophys. Res. Commun., 281, 827, 10.1006/bbrc.2001.4312 · DOI
  32. Lertkiatmongkol, 2016, Endothelial functions of platelet/endothelial cell adhesion molecule-1 (CD31), Curr. Opin. Hematol., 23, 253, 10.1097/MOH.0000000000000239 · DOI · Paper page
  33. Ilan, 2001, PECAM-1 shedding during apoptosis generates a membrane-anchored truncated molecule with unique signaling characteristics, FASEB J., 15, 362, 10.1096/fj.00-0372com · DOI · Paper page
  34. Goldberger, 1994, Biosynthesis and processing of the cell adhesion molecule PECAM-1 includes production of a soluble form, J. Biol. Chem., 269, 17183, 10.1016/S0021-9258(17)32538-3 · DOI
  35. Zaremba, 2002, sPECAM-1 in serum and CSF of acute ischaemic stroke patients, Acta Neurol. Scand., 106, 292, 10.1034/j.1600-0404.2002.01339.x · doi:10.1034/j.1600-0404.2002.01339.x
  36. Zaremba, 2002, Soluble platelet endothelial cell adhesion molecule-1 in ischaemic stroke patients is related to the extent of early brain damage, Cent. J. Immunol., 27, 90
  37. Banerjee, 2008, CD38/Cyclic ADP-Ribose Regulates Astrocyte Calcium Signaling: Implications for Neuroinflammation and HIV-1-Associated Dementia, J. Neuroimmune Pharmacol., 3, 154, 10.1007/s11481-008-9105-7 · DOI
  38. Levy, 2012, CD38 deficiency in the tumor microenvironment attenuates glioma progression and modulates features of tumor-associated microglia/macrophages, Neuro. Oncol., 14, 1037, 10.1093/neuonc/nos121 · DOI
  39. Blacher, 2015, Inhibition of glioma progression by a newly discovered CD38 inhibitor, Int. J. Cancer, 136, 1422, 10.1002/ijc.29095 · DOI · Paper page
  40. Wang, 2017, Blocking the CD38/cADPR pathway plays a double-edged role in LPS stimulated microglia, Neuroscience, 361, 34, 10.1016/j.neuroscience.2017.08.010 · DOI
  41. Wakade, C., Chong, R., Bradley, E., Thomas, B., and Morgan, J. (2014). Upregulation of GPR109A in Parkinson’s Disease. PLoS ONE, 9. · DOI · Paper page
  42. Wang, 2017, Deletion of Nampt in Projection Neurons of Adult Mice Leads to Motor Dysfunction, Neurodegeneration, and Death, Cell Rep., 20, 2184, 10.1016/j.celrep.2017.08.022 · DOI
  43. Braidy, 2013, Serum nicotinamide adenine dinucleotide levels through disease course in multiple sclerosis, Brain Res., 1537, 267, 10.1016/j.brainres.2013.08.025 · DOI
  44. Otsuka, 1994, Immunoreactivity in Alzheimer’s neurofibrillary tangles (abstract), Brain Pathol., 4, 558
  45. Jude, 2012, miR-140-3p regulation of TNF-α-induced CD38 expression in human airway smooth muscle cells, Am. J. Physiol. Lung Cell. Mol. Physiol., 303, L460, 10.1152/ajplung.00041.2012 · DOI
  46. Dileepan, 2014, MicroRNA-708 regulates CD38 expression through signaling pathways JNK MAP kinase and PTEN/AKT in human airway smooth muscle cells, Respir. Res., 15, 107, 10.1186/s12931-014-0107-0 · DOI
  47. Saad, 2011, Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson’s disease in the European population, Hum. Mol. Genet., 20, 615, 10.1093/hmg/ddq497 · DOI · Paper page
  48. Choe, C., Lardong, K., Gelderblom, M., Ludewig, P., Leypoldt, F., Koch-Nolte, F., Gerloff, C., and Magnus, T. (2011). CD38 Exacerbates Focal Cytokine Production, Postischemic Inflammation and Brain Injury after Focal Cerebral Ischemia. PLoS ONE, 6. · DOI
  49. Kim, 2016, Impaired learning and memory in CD38 null mutant mice, Mol. Brain, 9, 16, 10.1186/s13041-016-0195-5 · DOI · Paper page
  50. Herrmann, 2016, Identification of gene expression patterns crucially involved in experimental autoimmune encephalomyelitis and multiple sclerosis, Dis. Model. Mech., 9, 1211
  51. Roboon, 2019, Deletion of CD38 Suppresses Glial Activation and Neuroinflammation in a Mouse Model of Demyelination, Front. Cell. Neurosci., 13, 258, 10.3389/fncel.2019.00258 · DOI · Paper page
  52. Turnquist, 2016, p53 isoforms regulate astrocyte-mediated neuroprotection and neurodegeneration, Cell Death Differ., 23, 1515, 10.1038/cdd.2016.37 · DOI · Paper page
  53. Covarrubias, A.J., Kale, A., Perrone, R., Lopez-Dominguez, J.A., Pisco, A.O., Kasler, H.G., Schmidt, M.S., Wiley, C.D., Iyer, S.S., and Basisty, N. (2019). Aging-related inflammation driven by cellular senescence enhances NAD consumption via activation of CD38+ pro-inflammatory macrophages. bioRxiv, 609438. · doi:10.1101/609438
  54. Chini, 2018, A Potent and Specific CD38 Inhibitor Ameliorates Age-Related Metabolic Dysfunction by Reversing Tissue NAD+ Decline, Cell Metab., 27, 1081, 10.1016/j.cmet.2018.03.016 · DOI · Paper page
  55. Usmani, 2018, CD38 Antibodies in Multiple Myeloma: Mechanisms of Action and Modes of Resistance, Front. Immunol., 9, 2134, 10.3389/fimmu.2018.02134 · DOI · Paper page
  56. Hogan, K.A., Chini, C.C.S., and Chini, E.N. (2019). The Multi-faceted Ecto-enzyme CD38: Roles in immunomodulation, cancer, aging, and metabolic diseases. Front. Immunol., 10. · DOI · Paper page
  57. Milo, 2019, Therapies for multiple sclerosis targeting B cells, Croat. Med. J., 60, 87, 10.3325/cmj.2019.60.87 · DOI

Cited by

See all 141

Metadata

Authors
Guerreiro, S., Privat, A.-L., Bressac, L., & Toulorge, D.
Venue
Cells
Publisher
MDPI AG
Published
2020-02-18
Volume
9
Issue
2
Pages
471
ISSN
2073-4409 (ISSN-L)
OpenAlex
W3008840800
Cited by
141
References
21
FWCI
5.73
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CD38 in Neurodegeneration and Neuroinflammation. https://app.cochat.ai/papers/10.3390/cells9020471
The paper
Guerreiro, S., Privat, A.-L., Bressac, L., & Toulorge, D. (2020). CD38 in Neurodegeneration and Neuroinflammation. Cells. https://doi.org/10.3390/cells9020471

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.